Investor Stock List
Ranked #3,013 of 8,699 institutional investors

Tetragon Partners GP Ltd

Grand Cayman, E9

$681M
US stock portfolio at live prices · today −$20.8M (−2.97%)
Market closed. Prices as of Nov 20, 8:11 AM ET
Value at quarter end (Q3 2026)
$758M
Change from Q2 2026
+$143.2M (+23.31%)
Positions
29 · 4 new, 4 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $8.5M of stock. $41.8M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
PATH 53.6%SLN 7.09%KGEI 4.64%LYFT 2.48%WK 2.13%
StockSharesValue, live% of portfoliovs Q2 2026
PATH UiPath, Inc.32,500,000$365M53.6%Added +5%
SLN Silence Therapeutics plc2,436,051$48.3M7.09%Added +219%
KGEI Kolibri Global Energy Inc.6,834,504$31.6M4.64%Unchanged
LYFT Lyft, Inc.1,000,000$16.9M2.48%Unchanged
WK Workiva Inc.225,000$14.5M2.13%Reduced −10%
CXM Sprinklr, Inc.2,200,000$14.3M2.11%Unchanged
IONS Ionis Pharmaceuticals, Inc.440,930$12.0M1.76%Added +354%
MBX MBX Biosciences, Inc.220,647$11.8M1.73%Added +8%
ARWR Arrowhead Pharmaceuticals, Inc.264,040$11.5M1.69%Added +102%
AUTL Autolus Therapeutics plc9,500,000$9.3M1.37%Unchanged
DFTX Definium Therapeutics, Inc.310,892$9.2M1.35%Added +8%
IMVT Immunovant, Inc.275,219$9.0M1.31%Added +8%
CLDX Celldex Therapeutics, Inc.295,941$8.3M1.22%Added +2%
ALKT Alkami Technology, Inc.650,000$8.2M1.21%Added +8%
DYN Dyne Therapeutics, Inc.511,280$8.2M1.20%Added +43%
HRMY Harmony Biosciences Holdings, Inc.226,677$7.5M1.10%Added +13%
NBIX Neurocrine Biosciences, Inc.47,014$7.4M1.08%New
RLAY Relay Therapeutics, Inc.447,235$7.1M1.04%Reduced −22%
KRYS Krystal Biotech, Inc.19,668$6.2M0.91%Unchanged
AGIO Agios Pharmaceuticals, Inc.215,529$6.2M0.91%Added +5%
CELC Celcuity Inc.87,421$4.9M0.72%Added +36%
AXSM Axsome Therapeutics, Inc.35,000$4.7M0.70%New
UBER Uber Technologies, Inc.71,428$4.7M0.69%New
NKTR Nektar Therapeutics101,645$3.3M0.49%Added +17%
ANTX AN2 Therapeutics, Inc.603,424$3.1M0.46%New
SNOW Snowflake Inc.10,000$2.7M0.39%Unchanged
ANNX Annexon, Inc.655,948$2.2M0.33%Reduced −47%
TECX Tectonic Therapeutic, Inc.26,798$564K<0.1%Reduced −42%
GLUE Monte Rosa Therapeutics, Inc.56,052$499K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
AMLX Amylyx Pharmaceuticals, Inc.297,926$7.8M
ACAD Acadia Pharmaceuticals Inc.167,875$3.0M
ACRS Aclaris Therapeutics, Inc.400,000$1.4M
CUE Cue Biopharma, Inc.93,819$422K